Category: 3. Business

  • Noel Clarke loses libel case against Guardian over sexual misconduct investigation | The Guardian

    Noel Clarke loses libel case against Guardian over sexual misconduct investigation | The Guardian

    The Guardian has successfully defended a libel action brought by the actor Noel Clarke over an investigation by the newspaper in which he was accused of sexual misconduct by more than 20 women.

    In a high court judgment handed down on Friday, Mrs Justice Steyn rejected Clarke’s claim. He had said the allegations set out in the Guardian’s investigation were false and that he had been the victim of an unlawful conspiracy.

    Clarke, 49, had said he would seek £70m in damages if successful.

    The Guardian relied on testimony from almost 30 people, 18 of whom gave accounts in court about their experiences of working with Clarke, a former star of Doctor Who.

    Many said they had been directly affected by Clarke, while others said they had witnessed inappropriate behaviour.

    The Guardian argued the allegations were true and that the articles and podcast about him were in the public interest.

    The writer and producer of the Kidulthood trilogy sued Guardian News & Media (GNM) over seven articles and a podcast published between April 2021 and March 2022 in which more than 20 women accused him of sexual misconduct.

    The allegations against Clarke were made up of the following elements:

    • There were strong grounds to believe that over 15 years, he used his power to prey on and harass female colleagues.

    • He sometimes bullied female colleagues.

    • He engaged in unwanted sexual contact, kissing, touching or groping.

    • He engaged in sexually inappropriate behaviour and comments.

    • He was involved in professional misconduct.

    • He took and shared explicit pictures and videos without consent, including secretly filming a young actor’s naked audition.

    In closing submissions, Gavin Millar KC, for the Guardian, said Clarke had been forced to come up with an “elaborate conspiracy theory” to try to rebut the “overwhelming evidence” against him.

    Clarke had been shown to be “precisely the man” depicted in the Guardian’s articles accusing him of sexual misconduct, vindicating its journalism, the high court heard.

    The actor had denied all the allegations and variously claimed that his accusers were lying, embellishing incidents, motivated by grudges and that there was a conspiracy against him.

    At the conclusion of the trial, Philip Williams, representing Clarke, argued that his client was the victim of an industry attempting a “purge” in the wake of the #MeToo movement. He highlighted the Benny Hill and Little Britain series and Carry On films as productions that would now be considered “inappropriate”, and said the treatment of Clarke “represents illiterate historical revisionism and completely ignores any nuance or context”.

    Millar said Clarke had “made unpersuasive but revealing efforts to normalise and/or excuse conduct that most people would find – and would have found, whether 10 or 20 years ago – offensive and unacceptable”.

    Steyn’s judgment means Clarke, who said his career had collapsed as a result of the articles, faces a hefty legal bill and may also be required to pay the bulk of the Guardian’s legal costs.

    The trial was a rare case of #MeToo-type allegations published by a UK newspaper going to trial. A victory for Clarke would have been likely to make the press rethink future reporting on such issues.

    After the publication of the Guardian’s first report on Clarke, Bafta suspended a lifetime achievement award that it had given him the previous week and ITV declined to broadcast the final episode of the thriller Viewpoint, in which he was starring.

    Additionally, Sky cancelled the award-winning police show Bulletproof, which was created by and starred Clarke. He also left Unstoppable Film and TV, the production company he co-founded and which produced Bulletproof.

    Continue Reading

  • DeepSeek hints latest model supported by China’s ‘next generation’ homegrown AI chips

    DeepSeek hints latest model supported by China’s ‘next generation’ homegrown AI chips

    Anthony Kwan | Getty Images News | Getty Images

    Chinese artificial intelligence startup DeepSeek has hinted that China will soon have homegrown “next generation” chips to support its AI models, while announcing an update to one of its large language models. 

    In a comment under a post on its official WeChat account, DeepSeek said the “UE8M0 FP8” precision format of its newly released model V3.1 is tailored for the next-generation domestically built chips that will be launched soon.

    FP8, or 8-bit floating point, is a data processing format that can boost the computational efficiency for training and inference of large deep learning models.

    DeepSeek’s mention of China’s coming next-generation chips may signal plans to work more closely with China’s emerging AI chip ecosystem in the face of Washington’s advanced semiconductor export restrictions and Beijing’s push for chip self-sufficiency.

    The comments come about two weeks after Beijing reportedly urged Chinese AI developers to use domestic alternatives to Nvidia’s graphics processing units used in AI training. While analysts say China’s domestic AI chipmakers lag behind Nvidia in technological advancement and scale, players like Huawei have been making progress.

    In its Thursday post, DeepSeek did not disclose the chips it used to train the V3.1, or what local chips the UE8M0 FP8 might be compatible with.

    DeepSeek shook up the tech world earlier this year after it released its R1 reasoning model, which demonstrated capabilities comparable to those of Western competitors like OpenAI, despite U.S. export controls restricting it from using Nvidia’s most advanced AI training chips.

    Prior to that, in December, the company released its V3 model, which it said had been trained on about 2,000 of Nvidia’s less advanced chips.

    Following DeepSeek’s model breakthroughs, the U.S. further tightened export restrictions in April, effectively banning Nvidia’s H20 chips, which had been specially designed to meet prior export restrictions on China. 

    Last month, officials from the Trump administration said they planned to allow Nvidia to resume shipping the chips to China. However, the H20s are now being met with scrutiny in China, with regulators reportedly mandating companies against buying the chips until a national security review is completed.

    Chip analysts have told CNBC that companies like Huawei that have been seeking to build an alternative AI chip ecosystem in China could benefit from a lack of Nvidia’s H20s in the market. 

    DeepSeek said Thursday that its V3.1 came with “major changes,” including faster response times, and a hybrid reasoning architecture that allows the model to support both reasoning and non-reasoning modes. Reasoning models can execute more complicated tasks through a step-by-step logical thought process.

    Starting Sept. 6, the company will also adjust the pricing for using the model’s API, which allows developers of other apps and web products to integrate DeepSeek on their platforms. 

    Continue Reading

  • FDA Approves New Option for NCFB

    FDA Approves New Option for NCFB

    The FDA has approved brensocatib tablets in 10-mg and 25-mg doses as once-daily treatment for non-cystic fibrosis bronchiectasis (NCFB) in adults and children aged 12 years or older, according to a press release from manufacturer Insmed.

    NCFB affects approximately 500,000 individuals in the US and millions globally, according to the press release. The condition is distinct from other respiratory infections, in that it involves widening of the airways rather than narrowing.

    Exacerbations involving coughing, increased mucus, and shortness of breath are common and disruptive, but targeted treatments have been lacking, according to the company. Brensocatib, marketed as Brinsupri, is a first-in-class inhibitor of DPP-1, designed to prevent the activation of neutrophils that drive the chronic airway inflammation in patients with NCFB, according to the press release.

    The approval was based on data from a phase 3 study known as ASPEN and a phase 2 study known as WILLOW. In the ASPEN study, patients with NCFB (1689 adults and 41 adolescents) randomized to 10 mg or 25 mg brensocatib daily had a 21.1% and 19.4% reduction in annual exacerbations, respectively, compared to placebo at 52 weeks. Forced expiratory volume in 1 second declined significantly in brensocatib patients compared to placebo patients, and significantly more brensocatib patients on either dose were exacerbation-free at 52 weeks.

    The WILLOW study, a 24-week randomized controlled trial, established the drug’s safety and efficacy based on time to first exacerbation. Brensocatib at both the 10-mg and 25-mg doses significantly extended the time to first exacerbation compared to placebo, and safety data showed no obvious relationships to treatment. Adverse events were mild to moderate in 66%, 88%, and 75% of the placebo, 10 mg, and 25 mg groups, respectively, and serious adverse events were similar across the groups. One death caused by progression of bronchiectasis was reported in a patient in the 25 mg brensocatib group.

    The approval authorizes the first treatment that directly targets the root cause of NCFB exacerbations, said ASPEN investigator Doreen Addrizzo-Harris, MD, NYU Grossman School of Medicine, New York City, in the press release. “Based on the strength of the data and the impact we’ve seen in patients, I believe this could become the new standard in non-cystic fibrosis bronchiectasis care,” she said.

    Brensocatib is indicated for treatment of NCFB at doses of 10 mg or 25 mg once daily in adults and adolescents aged 12 years or older, with no current contraindications, according to the prescribing information.

    Brensocatib is now available through a specialty pharmacy network in the US. In addition, brensocatib applications have been accepted by the European Medicines Agency and the Medicines and Healthcare products Regulatory Agency, and filing of an application in Japan is pending, according to the company, which expects commercial launches in these areas in 2026.

    The ASPEN and WILLOW studies were funded by brensocatib manufacturer Insmed.

    Continue Reading

  • Baker McKenzie Luxembourg and University of Lorraine Partner to Launch Scholarship | Newsroom

    Baker McKenzie Luxembourg and University of Lorraine Partner to Launch Scholarship | Newsroom

    Baker McKenzie is proud to announce its collaboration with the University of Lorraine through the Baker McKenzie Scholarship. This meaningful initiative underscores the Firm’s commitment to fostering equal opportunity and promoting diversity within the legal profession. It is designed to support outstanding students enrolled in a Master 1 or Master 2 in Law program by offering a unique career opportunity and financial support.

    Launched in January 2025 through a communication campaign within the University of Lorraine, the selection process attracted many talented individuals. Out of the many applications submitted, five students were invited to a final interview at Baker McKenzie’s Luxembourg office. The jury, which consisted of Jean-François Findling, Amar Hamouche, Elodie Duchene and Claire Danda was genuinely impressed by candidates’ remarkable presentations and unwavering determination. 

    Following the interviews, two exceptional laureates were chosen: Emma Boutra and Iris Okom, who were awarded an internship as well as financial support. To recognize their talent and commitment, the three other finalists have also been offered an internship. The Firm would like to extend sincere congratulations to all the participants for their dedication and authenticity, which made this inaugural edition truly memorable.

    Here are testimonials from the laureates:

    Mina Colson: 
    “The opportunity to complete my internship at Baker McKenzie in Luxembourg allowed me to confirm my particular interest in investment funds, significantly broaden my knowledge and reflect on the challenges of tomorrow.”

    Mariama Ndiaye: 
    “Working in Baker McKenzie’s international environment enabled me to affirm my interest in cross-border taxation and concretely prepare for the next chapter of my academic journey in Madrid.”

    Emma Boutra: 
    “Receiving the Baker McKenzie Scholarship is more than an honor, it’s a tangible boost to build the career I dream of: passing the CRFPA, pursuing an LLM abroad and practicing law beyond borders as a lawyer.”

    Iris Okom: 
    “The Baker McKenzie scholarship enabled me to finance my year of study abroad, a key step in my career. This concrete support, together with the internship offered, gives me the necessary impetus to build an international career and represents a valuable opportunity to discover the demands of the professional world within a firm of international excellence.”

    We look forward to continuing this wonderful story with the University of Lorraine and welcoming our next talents!

    Continue Reading

  • Dollar firms as traders pare rate cut bets ahead of Powell speech – Reuters

    1. Dollar firms as traders pare rate cut bets ahead of Powell speech  Reuters
    2. Dollar gains before key Powell speech  Business Recorder
    3. U.S. Dollar Rallies As Composite PMI Beats Estimates: Analysis For EUR/USD, GBP/USD, USD/CAD, USD/JPY  FXEmpire
    4. USD mixed to lower as focus remains on Fed – Scotiabank  FXStreet
    5. US Dollar Index holds steady above 98.50, Jackson Hole Symposium in focus  Mitrade

    Continue Reading

  • Rolls-Royce SMR advances to final stage in Swedish nuclear competition

    Rolls-Royce SMR advances to final stage in Swedish nuclear competition

    Sweden is projected to require an additional 100–250 TWh of electricity over the next 25 years, and nuclear energy is set to play an important role in achieving that target. Vattenfall’s focus for the first units is at the Ringhals site on the Värö Peninsula, already home to a nuclear power station operated by Vattenfall.

    Each Rolls-Royce SMR ‘factory-built’ nuclear power plant will generate 470MWe of clean low-carbon electricity, enough to power a million homes for more than 60 years.

     

    Dan Gould, Rolls-Royce SMR
    M +44 (0) 7717 720809
    [email protected]
    https://www.rolls-royce-smr.com/


    Continue Reading

  • India moves to sharpen weather forecasting amid renewable energy push

    India moves to sharpen weather forecasting amid renewable energy push

    India is working to significantly improve the accuracy of its weather forecasting systems to meet the growing demands of its renewable energy sector, a senior government official said on Friday.

    With solar and wind energy generation highly dependent on local weather conditions, the country is finding traditional broad-scale forecasts – such as state-wide or regional predictions – no longer sufficient.

    “You need a very, very granular forecast,” Central Electricity Authority Chair Ghanshyam Prasad said at a BloombergNEF Summit on green energy, adding that the ability to track cloud movements at specific locations was now critical.
    Currently, India’s forecast resolution – the precision of weather predictions over small time intervals or areas – does not match 15-minute operating cycles of the power grid, where weather conditions can shift rapidly, he said. The goal was to improve the resolution to minimum possible distances, he added.

    Beyond short-term forecasting, the government is also focusing on building long-term predictive tools that can aid planners in projecting weather trends over multi-year horizons.


    “Across the world, nobody has that kind of visibility to forecast weather for that kind of horizon,” Prasad said. “But we are trying to build long-range forecasting tools which can give us at least some predictions.” These developments are seen as critical for ensuring power sector stability as India scales up its reliance on renewable sources. “Until we are able to do that, probably we will not be able to sustain the power sector as such,” Prasad said.

    New Delhi has curbed its solar and coal power output during periods of low demand to keep its power grid stable and ease congestion in power lines as green supply rises, the Ministry of New and Renewable Energy (MNRE) told Reuters earlier this week.

    India added a record 22 GW of new solar and wind capacity in the first half of 2025 and is planning to increase non-fossil fuel power capacity to 500 GW by 2030.

    As part of its reforms, the CEA is also shifting from a five-year energy planning cycle to an annual model.

    “That’s a challenge that we have taken – if I do it every year, that means I will be able to capture the forecast better,” the official said.

    Continue Reading

  • Better Power-Demand Forecasting Vital to India’s Renewable Goals

    Better Power-Demand Forecasting Vital to India’s Renewable Goals

    India needs to improve the way it forecasts power demand if it wants to inject more renewable energy into the grid while avoiding blackouts, according to Ghanshyam Prasad, chairman of the Central Electricity Authority.

    Generation has to reflect demand, Prasad said at the BloombergNEF summit in New Delhi on Friday, adding that 40 gigawatts of renewable capacity in the country is yet to find offtakers. The risk is the country ends up with stressed assets, something that the thermal power sector has experienced, he said.

    Continue Reading

  • India moves to sharpen weather forecasting amid renewable energy push – Reuters

    1. India moves to sharpen weather forecasting amid renewable energy push  Reuters
    2. Indian clean energy developers urged to align growth with demand  Business Recorder
    3. New Delhi sharpens weather forecasts to safeguard power in cities  urbanacres.in
    4. Industry Leaders Urge Policy Push on RE Transmission and Distribution  outlookbusiness.com
    5. India urged to synchronise renewable expansion with demand  Invezz

    Continue Reading

  • Commissioner inaugurates family park in Commissioner colony

    Commissioner inaugurates family park in Commissioner colony

    – Advertisement –

    Sargodha, Aug 22 (APP):Commissioner Sargodha Division Jahanzeb Awan on Friday inaugurated the newly constructed Family Park in Commissioner Colony.

    According to a spokesperson, the ceremony was attended by a large number of residents, dignitaries and officials, including Director General (DG) Parks and Horticulture Authority, Muhammad Arshad.

    Speaking on the occasion, the Commissioner said that despite limited resources, the administration was working diligently to enhance the city’s beauty and provide quality facilities to its residents. “The park features swings, benches, fencing, a variety of plants and a grassy ground, providing a pleasant environment for families to relax and enjoy”, he added.

    The Commissioner directed Sargodha Waste Management Company (SWMC) to place waste containers in the area to maintain cleanliness.

    On the occasion, the residents expressed gratitude to the Commissioner for his interest in developing the park and assured full ownership, maintenance and children also requested the conversion of an adjacent vacant land into a cricket ground, which will be considered by the authorities.

    The area was previously a dumping ground, causing foul odors and unsanitary conditions. The park’s construction was a significant improvement, reflecting the administration’s commitment to enhancing public spaces.

    Continue Reading